课题基金 / 基金详情

EPR-effect driven tumor delivery of multifunctional boron nanomedicine for neutron capture therapy

EPR-effect driven tumor delivery of multifunctional boron nanomedicine for neutron capture therapy
EPR效应驱动的多功能硼纳米药物的肿瘤递送用于中子捕获治疗
批准号:
22KF0311
负责人:
新留 琢郎
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for JSPS Fellows
财政年份:
2023
资助国家:
日本
项目状态:
已结题
起止时间:
2023-03-08 至 2024-03-31

项目摘要

项目成果

新留 琢郎的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We synthesized a water-soluble micellar drug called styrene maleic acid (SMA) copolymer conjugated glucosamine and boric acid (SGB-complex). It showed tumor selective accumulation based on EPR effect and excellent tumoricidal activity in vitro as well as various mouse tumor models. However, the precise chemical structure of SGB-complex and the detailed mode of action of cytotoxicity without neutron irradiation was not understood.During FY2022 period, I focused on the determination of molecular structure of SGB-complex by UV-vis, IR, NMR spectroscopy and liquid chromatography mass spectroscopy. We confirmed that the SMA-polymer bound to the glucosamine via amide bond and the boric acid was attached to glucosamine by di-ol bond (This works we reported at ACS Applied Biomaterials journal). Next, we try to find out the possible mechanism of in vitro cytotoxicity of SGB-complex. We hypothesized that SGB-complex might induce ER or mitochondrial stress in mild-hypoxia state. To support our hypothesis, we measure the ER stress marker phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2), C/-EBP homologous protein (CHOP), and Caspase 3 and 7 expressions after treating of our drug. Interestingly, we found the SGB-complex significantly increased various ER stress markers that confirmed our drug induces ER stress in hypoxia adapted cancer cells. We also measured the mitochondrial membrane potential after treatment of our drug, and data showed very less changes occurred compare to non-treated group. TEM image will be able to confirm whether any mitochondrial damage occur or not.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
研究室ホームページ
实验室主页
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of potent antipseudomonal β‐lactams by means of polycarboxylation of aminopenicillins
通过氨基青霉素多羧化作用开发强效抗假单胞菌β-内酰胺类药物
DOI: 10.1111/1348-0421.12930
发表时间: 2021
期刊: Microbiology and Immunology
影响因子: 2.6
作者: [Akter Shahinur, Migiyama Yohei, Tsutsuki Hiroyasu, Ono Katsuhiko, Hamasaki Chika, Zhang Tianli, Miyao Kenki, Toyomoto Touya, Yamamoto Keiichi, Islam Waliul, Sakagami Takuro, Matsui Hirotaka, Yamaguchi Yoshihiro, Sawa Tomohiro]
通讯作者: Sawa Tomohiro
A promising strategy for cancer treatment by using SMA-polymer encapsulated chlorophyll as a photodynamic therapy
使用 SMA 聚合物封装叶绿素作为光动力疗法治疗癌症的一种有前途的策略
DOI: --
发表时间: 2022
期刊:
影响因子: --
作者: [Waliul Islam, Jun Fang]
通讯作者: Jun Fang
A stable micelle of SMA-polymer encapsulated chlorophyll shows a potent anticancer effect as a photodynamic therapy
SMA 聚合物封装叶绿素的稳定胶束作为光动力疗法显示出有效的抗癌作用
DOI: --
发表时间: 2022
期刊:
影响因子: --
作者: [Waliul Islam, Ayaka Harada, Hiroyasu Tsutsuki, Jun Fang, Takuro Niidome, Tomohiro Sawa]
通讯作者: Tomohiro Sawa
細胞内寄生菌を標的とする革新的抗菌薬送達システムの構築
  • 批准号:
    23K25210
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $3.58万
  • 财政年份:
    2024
  • 负责人:
    新留 琢郎
  • 依托单位:
Innovative antibacterial drug delivery system to intracellular bacteria
  • 批准号:
    22H03956
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2022
  • 负责人:
    新留 琢郎
  • 依托单位:
磁場でコントルールできる抗菌活性磁性ナノ粒子の開発
  • 批准号:
    17F17411
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
  • 资助金额:
    $1.41万
  • 财政年份:
    2017
  • 负责人:
    新留 琢郎
  • 依托单位:
薬剤コートした金ナノ粒子を使ったトキソプラズマ感染症治療
  • 批准号:
    09F09063
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
  • 资助金额:
    $1.34万
  • 财政年份:
    2009
  • 负责人:
    新留 琢郎
  • 依托单位:
国内基金
海外基金
新型靶向硼药的研发及BNCT联合CAR-T治疗策略探索
基于多模态影像与语义引导的BNCT 快速精准剂量计算新方法及关 键技术研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    田锋
  • 依托单位:
利用PET显像构建靶向肿瘤细胞αvβ6与肿瘤间质FAPα“二维 ”载硼药物用于胰腺癌BNCT治疗
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    黄顺
  • 依托单位:
面向BNCT中子束流监测的高性能GEM中子谱仪关键技术研究
  • 批准号:
    12375297
  • 项目类别:
    面上项目
  • 资助金额:
    53万元
  • 批准年份:
    2023
  • 负责人:
    胡志猛
  • 依托单位: